Melanoma Therapeutics Market : Outlook Continues to Remain Positive by 2015 - 2021

The market for skin diseases and treatment are increasing significantly due to the rising prevalence of skin disorders such as skin cancer, skin infections, and skin allergies. Skin cancer may be of three types: basal cell carcinoma, squamous cell carcinoma, and melanoma. Melanoma refers to the type of skin cancer which forms from pigment-containing cells in the skin. It is more common in locations with a sunny climate and is most serious of all skin cancers. UV radiations are the primary causes of melanoma. However, genes can also cause melanoma. Treatments available for melanoma include surgery, radiation therapy, and pharmacotherapy. Adjuvant therapy, immunotherapy, and chemotherapy are the different types of therapies available in the market. The global market for melanoma therapeutics is increasing at a significant rate due to increase in the prevalence of melanoma and improvement in healthcare facilities. Moreover, government initiatives  and technical advancements boost growth of the melanoma therapeutics market. 

Request TOC :

North America dominates the global market for melanoma therapeutics due to increasing prevalence on melanoma and technical advancements in the region . In addition, increased awareness regarding the treatment of melanoma and improved healthcare facilities further drive the North American market for melanoma therapeutics. The Asia melanoma therapeutics market is expected to witness high growth rate in the next few years followed by Europe. China and India are expected to be the fastest-growing melanoma therapeutics markets in Asia  due to a large population base and increasing prevalence of melanoma in these countries. Some of the key driving factors of the melanoma therapeutics market in emerging countries are increasing awareness  and improved healthcare facilities.

Factors such as increased awareness, technological advancements, and high adoption rate of this therapeutics among patients have driven the global melanoma therapeutics market . In addition, government initiatives  have driven the market for melanoma therapeutics. However, factors such as lack of awareness  in some developing regions and high cost associated with the therapy are restraining growth of the global melanoma therapeutics market. Moreover, economic crisis and regulatory issues  are restraining the melanoma therapeutics market from growing.

Growing population and economies in the developing countries such as India and China  are expected to create substantial opportunities  for the global melanoma therapeutics market. Innovation of medicines with better efficiency  is expected to create substantial opportunities for the global melanoma therapeutics market. Availability of new drugs, with more efficacies, in the pipeline is expected to offer good opportunities for the global market for melanoma therapeutics.   

Buy Full Report @

However, reluctance among people to undergo therapies and surgeries is one of the major restraints for growth of the global melanoma therapeutics market. One of the latest trends in the global melanoma therapeutics is adoption of combination therapies. Some of the major companies in the global market for melanoma therapeutics are Bristol-Myers Squibb Co., Merck and Co., Inc., and F. Hoffmann-La Roche, Ltd. Some other companies with significant presence in the global market for melanoma therapeutics are AB Science S.A., Amgen, Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co., Ltd., GlaxoSmithKline, plc., Pfizer, Inc., and Vical, Inc.

Key geographies evaluated in this report are:

  • North America
    • U.S
    • Canada
  • Europe
    • France, Germany, Italy, Spain, and the UK
    • Eastern Europe
    • CIS
  • APAC
    • China
    • India
    • Japan
    • Australia
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others

Key features of this report

    • Drivers, restraints, and challenges shaping the Melanoma Therapeutics market dynamics
    • Latest innovations and key events in the industry
    • Analysis of business strategies of the top players
    • Melanoma Therapeutics market estimates and forecasts(2015 -2021)

    About Us

    Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

    PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.


    Persistence Market Research

    305 Broadway

    7th Floor, New York City,

    NY 10007, United States

    USA - Canada Toll Free: +1 800-961-0353